Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Susan C. Villegas"'
Autor:
Susan C. Villegas, Lorena Dima
Publikováno v:
American Journal of Therapeutics. 30:e117-e125
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::524b33203644d3c6671b05d3586b83e7
https://doi.org/10.1097/mjt.0000000000001608
https://doi.org/10.1097/mjt.0000000000001608
Autor:
Susan C. Villegas, Nikki Thielet
Publikováno v:
The Journal for Nurse Practitioners. 16:176-180
Methadone is an opioid agonist with unique pharmacologic and pharmacokinetic properties to consider when prescribing. Similar to other opioids, methadone is a Schedule II controlled substance; however, its indication for opioid use disorder includes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0fefe48984886334341b7f34285df38
https://doi.org/10.1016/j.nurpra.2019.12.017
https://doi.org/10.1016/j.nurpra.2019.12.017
Autor:
Robin L. Breitzka, Susan C. Villegas
Publikováno v:
Clinical Therapeutics. 34:14-23
Head lice infestations are responsible for social and economic distress. Despite a reported increase in resistance, permethrin 1% is still the first-line treatment of head lice. Alternative topical pediculicidal agents include malathion and benzyl al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e7be44794fe2b76f3bafec9297bc2f
https://doi.org/10.1016/j.clinthera.2011.11.026
https://doi.org/10.1016/j.clinthera.2011.11.026
Autor:
Ilir Agalliu, Susan C. Villegas, Alyssa H. Silver, Katherine O'Connor, Nora Esteban-Cruciani, Michael L. Rinke, Sheila Liewehr, Lindsey C. Douglas, Joanne M. Nazif, Diana S. Lee, Hai Jung H. Rhim, Gabriella Azzarone
Publikováno v:
Pediatrics. 136(6)
BACKGROUND AND OBJECTIVES:Bronchiolitis, the most common reason for hospitalization in children younger than 1 year in the United States, has no proven therapies effective beyond supportive care. We aimed to investigate the effect of nebulized 3% hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bba54662b37a97353ee3b2c87c13afa
https://pubmed.ncbi.nlm.nih.gov/26553190
https://pubmed.ncbi.nlm.nih.gov/26553190
Autor:
Susan C. Villegas
Publikováno v:
Journal of Developing Drugs.
®. Perampanel is approved for use in patients 12 years of age and older for the adjunctive treatment of partial-onset seizures with or without secondary generalized seizures [2]. Perampanel has a novel mechanism of action and is the first agent appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24484285c2f80fd0fec9052597571aa0
https://doi.org/10.4172/2329-6631.1000e132
https://doi.org/10.4172/2329-6631.1000e132
Autor:
Susan C. Villegas
Publikováno v:
Journal of Developing Drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d031d6edba6fd99f2819717046a43bb
https://doi.org/10.4172/2329-6631.1000e129
https://doi.org/10.4172/2329-6631.1000e129
Autor:
Susan C. Villegas
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 48(9)
Head lice infestations continue to be an issue in today's society, with an increase in economic cost and resistance. Spinosad 0.9% topical suspension was recently introduced in the U.S. market as a novel agent with both pediculicidal and ovicidal act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c3e6dfd0c7de534155d0044e9a4f8d
https://pubmed.ncbi.nlm.nih.gov/23032800
https://pubmed.ncbi.nlm.nih.gov/23032800